PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.02%
Revenue growth of 5.02% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
7.85%
Gross profit growth of 7.85% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
14.12%
EBIT growth of 14.12% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
30.87%
Operating income growth of 30.87% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
8.00%
Net income growth of 8.00% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
8.01%
EPS growth of 8.01% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
8.01%
Diluted EPS growth of 8.01% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
-0.00%
Share reduction while Healthcare median is 0.00%. Seth Klarman would see a relative advantage if others are diluting.
-0.00%
Diluted share reduction while Healthcare median is 0.00%. Seth Klarman would see an advantage if others are still diluting.
-100.00%
Dividend cuts while Healthcare median is 0.00%. Seth Klarman would see if others maintain or grow payouts, highlighting a relative weakness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.61%
10Y CAGR of 1.61% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
1.61%
5Y CAGR of 1.61% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
-23.57%
Negative 3Y CAGR while Healthcare median is 0.00%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
-100.00%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-100.00%
Negative 5Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
No Data
No Data available this quarter, please select a different quarter.
0.22%
Below 50% of Healthcare median. Jim Chanos would suspect deeper issues limiting long-term profit growth.
0.22%
Below 50% of Healthcare median. Jim Chanos would suspect deeper problems limiting mid-term profit potential.
-39.53%
Negative 3Y CAGR while Healthcare median is 0.00%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.39%
Negative 3Y equity/share growth while Healthcare median is 0.06%. Seth Klarman sees a short-term weakness if peers still expand net worth.
-100.00%
Dividend declines over 10 years while Healthcare median is 0.00%. Seth Klarman would see a relative disadvantage if peers consistently raised payouts.
-100.00%
Dividend cuts or stagnation while Healthcare median is 0.00%. Seth Klarman sees a disadvantage in shareholder returns vs. peers.
No Data
No Data available this quarter, please select a different quarter.
-99.58%
AR shrinking while Healthcare median grows. Seth Klarman sees potential advantage unless it signals declining demand.
-1.78%
Decreasing inventory while Healthcare is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
6.99%
Asset growth of 6.99% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
4.08%
BV/share growth of 4.08% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
10.80%
Debt growth of 10.80% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
63.10%
SG&A growth far above Healthcare median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.